A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension
Clinical trial NCT00644605 · COMPLETED
Trial details
- NCT number
- NCT00644605
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.